<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7707449</journal-id>
<journal-id journal-id-type="pubmed-jr-id">656</journal-id>
<journal-id journal-id-type="nlm-ta">Ann Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann. Neurol.</journal-id>
<journal-title-group>
<journal-title>Annals of neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0364-5134</issn>
<issn pub-type="epub">1531-8249</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26332183</article-id>
<article-id pub-id-type="pmc">7374762</article-id>
<article-id pub-id-type="doi">10.1002/ana.24513</article-id>
<article-id pub-id-type="manuscript">NIHMS753076</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Visual Evoked Potentials Detect Cortical Processing Deficits in Rett Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>LeBlanc</surname>
<given-names>Jocelyn J.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>DeGregorio</surname>
<given-names>Geneva</given-names>
</name>
<degrees>BA</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Centofante</surname>
<given-names>Eleonora</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vogel-Farley</surname>
<given-names>Vanessa K.</given-names>
</name>
<degrees>BA</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barnes</surname>
<given-names>Katherine</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaufmann</surname>
<given-names>Walter E.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fagiolini</surname>
<given-names>Michela</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nelson</surname>
<given-names>Charles A.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Laboratories of Cognitive Neuroscience, Division of Developmental Medicine, Boston Children’s Hospital, Boston;</aff>
<aff id="A2"><label>2</label>F. M. Kirby Neurobiology Center, Department of Neurology, Boston Children’s Hospital, Boston;</aff>
<aff id="A3"><label>3</label>Harvard Medical School, Boston;</aff>
<aff id="A4"><label>4</label>Rett Syndrome Program, Department of Neurology, Boston Children’s Hospital, Boston;</aff>
<aff id="A5"><label>5</label>Harvard Graduate School of Education, Cambridge, MA.</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Authorship</p>
<p id="P2">All authors contributed to designing the study and editing the manuscript. J.J.L. collected, analyzed, and interpreted the human data and wrote the manuscript. G.D. collected and analyzed the human data. E.C. collected, analyzed, and interpreted the mouse data. V.K.V.-F. was involved in study design and collected the human data. W.E.K. oversaw recruitment and phenotyping of the study participants, administered the CSS, designed analyses, and interpreted the data. K.B. recruited study participants and collected the phenotyping data. M.F. and C.A.N. designed and supervised the study and interpreted the data.</p>
</fn>
<corresp id="CR1">Address correspondence to Dr Fagiolini, Boston Children’s Hospital, CLS 13034, 300 Longwood Avenue, Boston, MA 02115. <email>michela.fagiolini@childrens.harvard.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P48">Potential Conflicts of Interest</p>
<p id="P49">None to report.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>22</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>78</volume>
<issue>5</issue>
<fpage>775</fpage>
<lpage>786</lpage>
<!--elocation-id from pubmed: 10.1002/ana.24513-->
<abstract id="ABS1">
<sec id="S1">
<title>Objective:</title>
<p id="P3">Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutation of the X-linked <italic>MECP2</italic> gene and characterized by developmental regression during the first few years of life. The objective of this study was to investigate if the visual evoked potential (VEP) could be used as an unbiased, quantitative biomarker to monitor brain function in RTT.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P4">We recorded pattern-reversal VEPs in <italic>Mecp2</italic> heterozygous female mice and 34 girls with RTT. The amplitudes and latencies of VEP waveform components were quantified, and were related to disease stage, clinical severity, and <italic>MECP2</italic> mutation type in patients. Visual acuity was also assessed in both mice and patients by modulating the spatial frequency of the stimuli.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P5"><italic>Mecp2</italic> heterozygous female mice and RTT patients exhibited a similar decrease in VEP amplitude that was most striking in the later stages of the disorder. RTT patients also displayed a slower recovery from the principal peak of the VEP response that was impacted by <italic>MECP2</italic> mutation type. When the spatial frequency of the stimulus was increased, both patients and mice displayed a deficit in discriminating smaller patterns, indicating lower visual spatial acuity in RTT.</p>
</sec>
<sec id="S4">
<title>Interpretation:</title>
<p id="P6">VEP is a method that can be used to assess brain function across species and in children with severe disabilities like RTT. Our findings support the introduction of standardized VEP analysis in clinical and research settings to probe the neurobiological mechanism underlying functional impairment and to longitudinally monitor progression of the disorder and response to treatment.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>